Download: From Safety Governance to Benefit Risk Governance

At last year’s World Drug Safety Congress Europe, Peter Verdru, MD, Safety Sciences, UCB gave a presentation on “From Safety Governance to Benefit Risk Governance.” Verdru mentions that the continuous safety profile monitoring and benefit risk evaluation of authorised medicinal products is critical to pharmacovigilance processes.  He goes on to discuss in depth, Benefit Risk Teams, Benefit Risk membership, Benefit Risk board …